NAKI Therapeutics
Summit
About NAKI Therapeutics
NAKI Therapeutics is a research-focused biopharmaceutical company developing Chimeric Antigen Receptor (CAR)-Natural Killer (NK) immunotherapy used to kill cancer cells effectively and safely compared to existing treatments. The company was founded in 2020 and is headquartered in Summit, New Jersey.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Last round: Series Unknown (Jan 2023)
- Website: nakitherapeutics.com
Industries & Categories
Biopharma, Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/naki-therapeutics-2235495 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.